Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants

OBJECTIVE: ACAN gene variants are an important cause of familial short stature (FSS). Appropriate growth-promoting therapies effectively improve the patient height. Here, we report a therapeutic assessment of cases of seven families of FSS patients with heterozygous ACAN variants. Our findings provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Jiang, Lihong, Liu, Geli, Ma, Chen, Zheng, Jiaqi, Niu, Lele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940281/
https://www.ncbi.nlm.nih.gov/pubmed/35330881
http://dx.doi.org/10.3389/fped.2022.819074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940281/
https://www.ncbi.nlm.nih.gov/pubmed/35330881
http://dx.doi.org/10.3389/fped.2022.819074

Ejemplares similares